Known targets — ChEMBL curated mechanism
rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Stearic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 7/20 | 0.72 |
| ▸ | CA1 | P00915 | 1/20 | 0.71 |
| ▸ | CES2 | O00748 | 4/20 | 0.67 |
| ▸ | CES1 | P23141 | 4/20 | 0.67 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.57 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.57 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.57 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.57 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.57 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Myristic Acid SCHEMBL3766828 | 1.00 | FABP3 (0.72) | FABP3CA1CES2CES1FFAR3 | |
| Octanoic Acid SCHEMBL5440529 | 1.00 | FABP3 (0.72) | FABP3CA1CES2CES1FFAR3 | |
| Dodecanoate SCHEMBL11308543 | 1.00 | FABP3 (0.72) | FABP3CA1CES2CES1FFAR3 | |
| Behenic Acid SCHEMBL3452341 | 1.00 | FABP3 (0.72) | FABP3CA1CES2CES1FFAR3 | |
| Decanoic Acid SCHEMBL9239460 | 1.00 | FABP3 (0.72) | FABP3CA1CES2CES1FFAR3 | |
| Palmitic Acid SCHEMBL11681730 | 1.00 | FABP3 (0.72) | FABP3CA1CES2CES1FFAR3 | |
| Octanoic Acid SCHEMBL1316022 | 0.97 | FABP3 (0.75) | FABP3CA1CES2CES1FFAR3 | |
| Palmitic Acid SCHEMBL1628227 | 0.97 | FABP3 (0.75) | FABP3CA1CES2CES1FFAR3 | |
| Myristic Acid SCHEMBL3765071 | 0.97 | FABP3 (0.75) | FABP3CA1CES2CES1FFAR3 | |
| Stearic Acid SCHEMBL1360333 | 0.97 | FABP3 (0.75) | FABP3CA1CES2CES1FFAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9956028-B2 | Apparatus and method for heating biological targets | INNOVOLINK, LLC (US) | 2018-05-01 | — | — | US | claimed |
| EP-2709714-A1 | APPARATUS AND METHOD FOR HEATING A TREATMENT REGION WITH AN ALTERNATING ELECTRIC FIELD | Innovolink, LLC (US) | 2014-03-26 | — | — | EP | claimed |
| WO-2012154736-A1 | APPARATUS AND METHOD FOR HEATING A TREATMENT REGION WITH AN ALTERNATING ELECTRIC FIELD | INNOVOLINK, LLC (US) | 2012-11-15 | — | — | WO | claimed |
| US-20120289955-A1 | Apparatus and Method for Heating Biological Targets | INNOVOLINK, LLC | 2012-11-15 | — | — | US | claimed |
| US-4082879-A | REDUCIBLE METAL SOAP, REDUCING AGENT, POLYCYCLIC AROMATIC DYE AS STABILIZER | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1978-04-04 | — | — | US | claimed |
| CN-114410082-B | Modified polylactic acid with gradient crystallinity, and preparation method and application thereof | 湖南工业大学 | 2023-04-28 | — | — | CN | disclosed |
| CN-114410082-A | Modified polylactic acid with gradient crystallinity as well as preparation method and application thereof | 湖南工业大学 | 2022-04-29 | — | — | CN | disclosed |
| US-20220047050-A1 | PERSONAL ANTIMICROBIAL CARRIER | PAC X, LLC | 2022-02-17 | — | — | US | disclosed |
| WO-2022036259-A1 | PERSONAL ANTIMICROBIAL CARRIER | PAC X, LLC (US) | 2022-02-17 | — | — | WO | disclosed |
| US-11013730-B1 | Composition comprising selenazol or thiazalone derivatives and silver and method of treatment therewith | THIOREDOXIN SYSTEMS AB (SE) | 2021-05-25 | — | — | US | disclosed |
| EP-2709714-B1 | APPARATUS FOR HEATING A TREATMENT REGION WITH AN ALTERNATING ELECTRIC FIELD | INNOVOLINK LLC (US) | 2019-01-16 | — | — | EP | disclosed |
| US-10058542-B1 | Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith | THIOREDOXIN SYSTEMS AB (SE) | 2018-08-28 | — | — | US | disclosed |
| US-4030931-A | PHOTOGRAPHY, SILVER HALIDES | FUJI PHOTO FILM CO., LTD. (JA) | 1977-06-21 | — | — | US | disclosed |
| US-4028129-A | CONTAINING AN INORGANIC PEROXIDE OR A PEROXODISULFATE TO INHIBIT FOGGING | FUJI PHOTO FILM CO., LTD. (JA) | 1977-06-07 | — | — | US | disclosed |
| US-4021240-A | DIFFUSION, SILVER HALIDE OXIDIZER | EASTMAN KODAK COMPANY (US) | 1977-05-03 | — | — | US | disclosed |
| US-RE29168-E | HEAT SENSITIVE, ANTIHALATION LAYER | EASTMAN KODAK COMPANY (US) | 1977-04-05 | — | — | US | disclosed |
| US-4002479-A | ORGANIC SILVER SALT, SILVER HALIDE, AND A REDUCING AGENT | FUJI PHOTO FILM CO., LTD. (JA) | 1977-01-11 | — | — | US | disclosed |
| US-3985565-A | Photothermographic, composition using a phenolic leuco dye as a reducing agent | EASTMAN KODAK COMPANY (US) | 1976-10-12 | — | — | US | disclosed |
| US-3984249-A | TREATING WITH HYDROGEN | EASTMAN KODAK COMPANY (US) | 1976-10-05 | — | — | US | disclosed |
| US-3955982-A | HYDROCARBONS, HAL | EASTMAN KODAK COMPANY (US) | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11013730-B1 | Composition comprising selenazol or thiazalone derivatives and silver and method of treatment therewith | SELENOI, TST, SCLY | FABP3 1220/4885CA1 3748/4885CES2 1370/4885 |
| US-10058542-B1 | Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith | SELENOI, TST, GSS | FABP3 1166/4885CA1 4100/4885CES2 1945/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.